Downregulation of ST6GAL2 Correlates to Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma

References

• Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Chandler KB, Costello CE, Rahimi N. Glycosylation in the Tumor Microenvironment: implications for Tumor Angiogenesis and Metastasis. Cells. 2019;8(6). doi:10.3390/cells8060544
   PubMed Web of Science ®Google Scholar
• Pearce OM, Läubli H. Sialic acids in cancer biology and immunity. Glycobiology. 2016;26(2):111–128. doi:10.1093/glycob/cwv097
   PubMed Web of Science ®Google Scholar
• Reily C, Stewart TJ, Renfrow MB, Novak J. Glycosylation in health and disease. Nat Rev Nephrol. 2019;15(6):346–366.
   PubMed Web of Science ®Google Scholar
• Matsubara N, Imamura A, Yonemizu T, et al. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice. Front Immunol. 2018;9:820. doi:10.3389/fimmu.2018.00820
   PubMed Web of Science ®Google Scholar
• Giovannone N, Liang J, Antonopoulos A, et al. Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nat Commun. 2018;9(1):3287. doi:10.1038/s41467-018-05770-9
   PubMedGoogle Scholar
• Tsai CH, Tzeng SF, Chao TK, et al. Metastatic Progression of Prostate Cancer Is Mediated by Autonomous Binding of Galectin-4-O-Glycan to Cancer Cells. Cancer Res. 2016;76(19):5756–5767. doi:10.1158/0008-5472.CAN-16-0641
   PubMed Web of Science ®Google Scholar
• Tzeng SF, Tsai CH, Chao TK, et al. O-Glycosylation-mediated signaling circuit drives metastatic castration-resistant prostate cancer. FASEB j;2018. fj201800687. doi:10.1096/fj.201800687
   PubMed Web of Science ®Google Scholar
• Chou CH, Huang MJ, Chen CH, et al. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway. Oncotarget. 2015;6(8):6123–6135. doi:10.18632/oncotarget.3045
   PubMedGoogle Scholar
• Isaji T, Im S, Kameyama A, Wang Y, Fukuda T, Gu J. A complex between phosphatidylinositol 4-kinase IIα and integrin α3β1 is required for -glycan sialylation in cancer cells. J Biol Chem. 2019;294(12):4425–4436. doi:10.1074/jbc.RA118.005208
   PubMed Web of Science ®Google Scholar
• Lee M, Park JJ, Ko YG, Lee YS. Cleavage of ST6Gal I by radiation-induced BACE1 inhibits Golgi-anchored ST6Gal I-mediated sialylation of integrin β1 and migration in colon cancer cells. Radiat Oncol. 2012;7:47. doi:10.1186/1748-717X-7-47
   PubMed Web of Science ®Google Scholar
• Oswald DM, Zhou JY, Jones MB, Cobb BA. Disruption of hepatocyte Sialylation drives a T cell-dependent pro-inflammatory immune tone. Glycoconjugate J. 2020;37(3):395–407. doi:10.1007/s10719-020-09918-y
   PubMed Web of Science ®Google Scholar
• Wu Q, Yang Y, Xie D, et al. The sialylation profile of IgG determines the efficiency of antibody directed osteogenic differentiation of iMSCs by modulating local immune responses and osteoclastogenesis. Acta Biomater. 2020;114:221–232. doi:10.1016/j.actbio.2020.07.055
   PubMed Web of Science ®Google Scholar
• Lin WD, Fan TC, Hung JT, et al. Sialylation of CD55 by ST3GAL1 Facilitates Immune Evasion in Cancer. Cancer Immunol Res. 2021;9(1):113–122. doi:10.1158/2326-6066.CIR-20-0203
   PubMed Web of Science ®Google Scholar
• Bhide GP, Colley KJ. Sialylation of N-glycans: mechanism, cellular compartmentalization and function. Histochem Cell Biol. 2017;147(2):149–174. doi:10.1007/s00418-016-1520-x
   PubMed Web of Science ®Google Scholar
• Vajaria BN, Patel KR, Begum R, Patel PS. Sialylation: an Avenue to Target Cancer Cells. Pathol Oncol Res. 2016;22(3):443–447. doi:10.1007/s12253-015-0033-6
   PubMed Web of Science ®Google Scholar
• Perez S, Fu CW, Li WS. Sialyltransferase Inhibitors for the Treatment of Cancer Metastasis: current Challenges and Future Perspectives. Molecules. 2021;26(18):5673. doi:10.3390/molecules26185673
   PubMed Web of Science ®Google Scholar
• Dall’Olio F, Chiricolo M. Sialyltransferases in cancer. Glycoconjugate J. 2001;18(11–12):841–850. doi:10.1023/a:1022288022969
   PubMed Web of Science ®Google Scholar
• Mereiter S, Balmaña M, Campos D, Gomes J, Reis CA. Glycosylation in the Era of Cancer-Targeted Therapy: where Are We Heading? Cancer Cell. 2019;36(1):6–16. doi:10.1016/j.ccell.2019.06.006
   PubMed Web of Science ®Google Scholar
• Hugonnet M, Singh P, Haas Q, von Gunten S. The Distinct Roles of Sialyltransferases in Cancer Biology and Onco-Immunology. Int J Med. 2021;12.
   PubMedGoogle Scholar
• Krzewinski-Recchi MA, Julien S, Juliant S, et al. Identification and functional expression of a second human beta-galactoside alpha 2,6-sialyltransferase, ST6Gal II. Eur J Biochem. 2003;270(5):950–961. doi:10.1046/j.1432-1033.2003.03458.x
   PubMedGoogle Scholar
• Takashima S, Tsuji S, Tsujimoto M. Comparison of the enzymatic properties of mouse beta-galactoside alpha 2,6-sialyltransferases, ST6Gal I and II. J Biochem. 2003;134(2):287–296. doi:10.1093/jb/mvg142
   PubMed Web of Science ®Google Scholar
• Rohfritsch PF, Joosten JAF, Krzewinski-Recchi M-A, et al. Probing the substrate specificity of four different sialyltransferases using synthetic beta-D-Galp-(1-->4)-beta-D-GlcpNAc-(1-->2)-alpha-D-Manp-(1-->O) (CH(2))7CH3 analogues general activating effect of replacing N-acetylglucosamine by N-propionylglucosamine. Biochim Biophys Acta. 2006;1760(4):685–692. doi:10.1016/j.bbagen.2005.12.012
   PubMed Web of Science ®Google Scholar
• Jame-Chenarboo F, Ng HH, Macdonald D, Mahal LK. High-Throughput Analysis Reveals miRNA Upregulating α-2,6-Sialic Acid through Direct miRNA-mRNA Interactions. ACS Cent. Sci. 2022;8(11):1527–1536. doi:10.1021/acscentsci.2c00748
   PubMed Web of Science ®Google Scholar
• Xu G, Chen J, Wang G, et al. Resveratrol Inhibits the Tumorigenesis of Follicular Thyroid Cancer via ST6GAL2-Regulated Activation of the Hippo Signaling Pathway. Mol Ther Oncolytics. 2020;16:124–133. doi:10.1016/j.omto.2019.12.010
   PubMed Web of Science ®Google Scholar
• Liang L, Xu J, Wang M, et al. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge. Cell Death Dis. 2018;9(3):372. doi:10.1038/s41419-018-0382-7
   PubMedGoogle Scholar
• Liang A, Zhou B, Sun W. Integrated genomic characterization of cancer genes in glioma. Cancer Cell Int. 2017;17(1):90. doi:10.1186/s12935-017-0458-y
   PubMedGoogle Scholar
• Liu RJ, Cao X, Liang YJ, Du HB, Zao XB, Ye YA. ST6GAL2 IS A NOVEL PROGNOSTIC BIOMARKER AND ITS EXPRESSION CORRELATES TO IMMUNE CELL INFILTRATION IN HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022;76:S1339–S1339.
   Web of Science ®Google Scholar
• Vivian J, Rao AA, Nothaft FA, et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol. 2017;35(4):314–316. doi:10.1038/nbt.3772
   PubMed Web of Science ®Google Scholar
• Li C, Tang Z, Zhang W, Ye Z, Liu F. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA. Nucleic Acids Res. 2021;49(W1):W242–W246. doi:10.1093/nar/gkab418
   PubMed Web of Science ®Google Scholar
• Liu J, Lichtenberg T, Hoadley KA, et al. An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics. Cell. 2018;173(2).
   Web of Science ®Google Scholar
• Koch A, Jeschke J, Van Criekinge W, van Engeland M, De Meyer T. MEXPRESS update 2019. Nucleic Acids Res. 2019;47(W1):W561–W565. doi:10.1093/nar/gkz445
   PubMed Web of Science ®Google Scholar
• Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16(1):636. doi:10.1186/s12864-015-1847-z
   PubMed Web of Science ®Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8
   PubMed Web of Science ®Google Scholar
• Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics. 2012;16(5):284–287. doi:10.1089/omi.2011.0118
   PubMed Web of Science ®Google Scholar
• Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf. 2013;14(1):7. doi:10.1186/1471-2105-14-7
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202. doi:10.1093/bioinformatics/btz210
   PubMed Web of Science ®Google Scholar
• Zeng Z, Wong CJ, Yang L, et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 2022;50(D1):D1391–D1397. doi:10.1093/nar/gkab804
   PubMed Web of Science ®Google Scholar
• Liu C-J, F-F H, Xie G-Y, et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2022. doi:10.1093/bib/bbac310
   Web of Science ®Google Scholar
• Liu R, Cao X, Liang Y, et al. Downregulation of ST6GAL1 Promotes Liver Inflammation and Predicts Adverse Prognosis in Hepatocellular Carcinoma. J Inflamm Res. 2022;15:5801–5814. doi:10.2147/JIR.S385491
   PubMed Web of Science ®Google Scholar
• Neumann O, Kesselmeier M, Geffers R, et al. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors. Hepatology. 2012;56(5):1817–1827. doi:10.1002/hep.25870
   PubMed Web of Science ®Google Scholar
• Zuo S, Wei M, Wang S, Dong J, Wei J. Pan-Cancer Analysis of Immune Cell Infiltration Identifies a Prognostic Immune-Cell Characteristic Score (ICCS) in Lung Adenocarcinoma. Front Immunol. 2020;11:1218. doi:10.3389/fimmu.2020.01218
   PubMed Web of Science ®Google Scholar
• Zhou W, Ma Y, Zhang J, et al. Predictive model for inflammation grades of chronic hepatitis B: large-scale analysis of clinical parameters and gene expressions. Liver Int. 2017;37(11):1632–1641. doi:10.1111/liv.13427
   PubMed Web of Science ®Google Scholar
• Wang M, Gong Q, Zhang J, et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep. 2017;7(1):43446. doi:10.1038/srep43446
   PubMed Web of Science ®Google Scholar
• Wurmbach E, Chen Y-B, Khitrov G, et al. Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology. 2007;45(4):938–947. doi:10.1002/hep.21622
   PubMed Web of Science ®Google Scholar
• Liu Y, Qiu N, Shen L, et al. Nanocarrier-mediated immunogenic chemotherapy for triple negative breast cancer. J Control Release. 2020;323:431–441. doi:10.1016/j.jconrel.2020.04.040
   PubMed Web of Science ®Google Scholar
• Pinho SS, Reis CA. Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer. 2015;15(9):540–555. doi:10.1038/nrc3982
   PubMed Web of Science ®Google Scholar
• Papanicolau-Sengos A, Aldape K. DNA Methylation Profiling: an Emerging Paradigm for Cancer Diagnosis. Ann Rev Pathol. 2022;17:295–321. doi:10.1146/annurev-pathol-042220-022304
   PubMed Web of Science ®Google Scholar
• Jiang Y, Zhang H, Wang J, Liu Y, Luo T, Hua H. Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy. J Hematol Oncol. 2022;15(1):34. doi:10.1186/s13045-022-01252-0
   PubMed Web of Science ®Google Scholar
• Dong Y, Xie X, Wang Z, et al. Increasing matrix stiffness upregulates vascular endothelial growth factor expression in hepatocellular carcinoma cells mediated by integrin β1. Biochem Biophys Res Commun. 2014;444(3):427–432. doi:10.1016/j.bbrc.2014.01.079
   PubMed Web of Science ®Google Scholar
• Wu Y, Zhang Y, Qin X, Geng H, Zuo D, Zhao Q. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma. Pharmacol Res. 2020;160:105195. doi:10.1016/j.phrs.2020.105195
   PubMed Web of Science ®Google Scholar
• Ma XL, Shen MN, Hu B, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. J Hematol Oncol. 2019;12(1):37. doi:10.1186/s13045-019-0724-7
   PubMed Web of Science ®Google Scholar
• Sun F, Wang J, Sun Q, et al. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2019;38(1):449. doi:10.1186/s13046-019-1455-x
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• Elstrom RL, Bauer DE, Buzzai M, et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004;64(11):3892–3899. doi:10.1158/0008-5472.CAN-03-2904
   PubMed Web of Science ®Google Scholar
• Fu T, Dai L-J, S-Y W, et al. Spatial architecture of the immune microenvironment orchestrates tumor immunity and therapeutic response. J Hematol Oncol. 2021;14(1):98. doi:10.1186/s13045-021-01103-4
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Schreiber H, Fu Y-X. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–1022. doi:10.1038/ni.2703
   PubMed Web of Science ®Google Scholar
• Zhang Z, Ma L, Goswami S, et al. Landscape of infiltrating B cells and their clinical significance in human hepatocellular carcinoma. Oncoimmunology. 2019;8(4):56.
   Web of Science ®Google Scholar
• Hofmann M, Tauber C, Hensel N, Thimme R. CD8(+) T Cell Responses during HCV Infection and HCC. J Clin Med. 2021;10(5):991. doi:10.3390/jcm10050991
   PubMed Web of Science ®Google Scholar
• Garnelo M, Tan A, Her Z, et al. Interaction between tumour-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66(2):342–351. doi:10.1136/gutjnl-2015-310814
   PubMed Web of Science ®Google Scholar
• Kurebayashi Y, Ojima H, Tsujikawa H, et al. Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification. Hepatology. 2018;68(3):1025–1041. doi:10.1002/hep.29904
   PubMed Web of Science ®Google Scholar
• Verneau J, Sautés-Fridman C, Sun CM. Dendritic cells in the tumor microenvironment: prognostic and theranostic impact. Semin Immunol. 2020;48:101410. doi:10.1016/j.smim.2020.101410
   PubMed Web of Science ®Google Scholar